Risk of recurrence after a first unprovoked seizure

Epilepsia
Anne T Berg

Abstract

The risk of recurrence after a first unprovoked seizure has been examined in numerous observational studies and two large, high-quality randomized trials. Overall, in untreated individuals, 40-50% can expect a recurrence within 2 years of the initial seizure. Treatment may reduce this risk by as much as half. Those at the greatest risk of recurrence have either an abnormal EEG or an identifiable neurological condition or symptoms consistent with one ("symptomatic"). Status epilepticus and a history of febrile seizures may be associated with an increased risk of recurrence in individuals with symptomatic seizures. The great majority of people (approximately 90%) who are seen for a first unprovoked seizure attain a one to two year remission within 4 or 5 years of the initial event.

References

Mar 1, 1992·Archives of Neurology·C A van DonselaarA C Declerck
Oct 1, 1989·Developmental Medicine and Child Neurology·J BoullocheP Tron
Jan 1, 1986·Epilepsia·J F AnnegersL T Kurland
Feb 1, 1995·Brain : a Journal of Neurology·I E SchefferF Cendes
Feb 26, 1994·Lancet·I E SchefferJ I Manson
Mar 1, 1997·Brain : a Journal of Neurology·I E Scheffer, S F Berkovic
Feb 12, 1998·The New England Journal of Medicine·W A HauserV E Anderson
Apr 29, 1998·Current Opinion in Neurology·S F Berkovic, I E Scheffer
Jun 17, 2005·Expert Opinion on Pharmacotherapy·John M Galla, Kenneth W Mahaffey
Jul 9, 2005·BMJ : British Medical Journal·Ettore Beghi, Josemir W Sander
Feb 22, 2008·Epilepsia·W Allen Hauser, Ettore Beghi

❮ Previous
Next ❯

Citations

Aug 24, 2010·Current Treatment Options in Neurology·John D Hixson
May 10, 2013·Current Treatment Options in Neurology·Omar Siddiqi, Gretchen L Birbeck
Jul 16, 2011·Epilepsia·Bernd Pohlmann-Eden
Sep 18, 2008·International Journal of Clinical Practice·S Sathasivam, A Nicolson
Feb 11, 2010·Case Reports in Medicine·Pierre LahmekHenri-Jean Aubin
May 9, 2012·Annals of Indian Academy of Neurology·Roop Gursahani, Namit Gupta
Jan 12, 2013·Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række·Anita HerigstadHarald Aurlien
Jun 20, 2012·Neurochemistry International·Olav B SmelandUrsula Sonnewald
Sep 13, 2015·Seizure : the Journal of the British Epilepsy Association·Prakash PaliwalRahul Rathakrishnan
Feb 25, 2014·Seizure : the Journal of the British Epilepsy Association·M de ZélicourtF Fagnani
Sep 4, 2010·British Journal of Haematology·Susanna B AliAmza Ali
Feb 15, 2013·Acta Neurologica Scandinavica·I GoldbergR Gandelman-Marton
Oct 29, 2010·Developmental Disabilities Research Reviews·Dewi Frances T Depositario-Cabacar, Tesfaye-Getaneh Zelleke
Aug 13, 2015·Epilepsy & Behavior : E&B·Ivan RektorAmos D Korczyn
Jul 30, 2015·Epilepsia·Nicholas LawnJohn Dunne
Feb 14, 2015·Pediatrics International : Official Journal of the Japan Pediatric Society·Sonoko MizorogiMasao Aihara
Aug 14, 2015·Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række·Martha Seim RealfsenKarl O Nakken
Jul 25, 2013·Seizure : the Journal of the British Epilepsy Association·Laxmi Narayan SharmaHardeep Singh Malhotra
Apr 29, 2014·Journal of Neurology, Neurosurgery, and Psychiatry·J W L BrownJ W Dunne
Nov 28, 2012·Neurophysiologie clinique = Clinical neurophysiology·L MaillardH Vespignani
Sep 24, 2013·Epilepsy Research·Nicholas LawnAndrew Wesseldine
Apr 30, 2013·Seizure : the Journal of the British Epilepsy Association·Jessica Askamp, Michel J A M van Putten
Apr 7, 2012·Seizure : the Journal of the British Epilepsy Association·Gavin P Winston, Stephan R Jaiser
Mar 25, 2014·Epilepsy & Behavior : E&B·Nicholas LawnJohn Dunne
May 27, 2014·Brain & Development·Eli HeymanRevital Gandelman-Marton
Jun 28, 2016·Seizure : the Journal of the British Epilepsy Association·Tao ChenLing Liu
Aug 6, 2016·Epilepsy & Behavior : E&B·Michal TavorShlomo Moshe
Oct 1, 2016·Jornal de pediatria·Catarina MaiaCecília Martins
Dec 24, 2010·Therapeutic Advances in Neurological Disorders·Ettore Beghi
Oct 8, 2017·The Cochrane Database of Systematic Reviews·Pankaj B ShahS Elayaraja
Aug 28, 2018·Epilepsia·Claudine SculierTobias Loddenkemper
May 31, 2014·Stroke; a Journal of Cerebral Circulation·Elena HaapaniemiAtte Meretoja
Dec 20, 2017·Current Opinion in Neurology·Albrecht Kunze, Markus Reuber
Oct 17, 2019·Acta Neurologica Scandinavica·Sachin KumarYogendra Kumar Gupta
Sep 19, 2019·Acta Neurologica Scandinavica·Antonio Gil-NagelCristina Tato
May 12, 2009·The Neurologist·Jerry J Shih, Juan G Ochoa
Apr 10, 2020·The Cochrane Database of Systematic Reviews·Pankaj B ShahSivaprakasam Elayaraja
May 7, 2016·The Cochrane Database of Systematic Reviews·Maurizio A LeoneEttore Beghi
Jan 20, 2016·Journal of Neurology, Neurosurgery, and Psychiatry·Gail S BellJosemir W Sander

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.